NRSN – neurosense therapeutics ltd. (US:NASDAQ)
Stock Stats
News
NeuroSense Therapeutics (NRSN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.
NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout
PrimeC New Data to Be Presented at AD/PD™ 2026 Conference [Yahoo! Finance]
PrimeC New Data to Be Presented at AD/PD™ 2026 Conference
NeuroSense Therapeutics (NRSN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.
Form 6-K NeuroSense Therapeutics For: Mar 24
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Pellizzari Christine A
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Claiborne Cary J
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Tracik Ferenc
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Leuchtenberger Mark
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.